Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Brain Neoplasms 4Neuroblastoma 3Recurrence 2Melanoma 2Medulloblastoma 2Glioblastoma 2Neoplasm Metastasis 1Gliosarcoma 1Disease Progression 1Central Nervous System Neoplasms 1Breast Neoplasms 1

Interventions

Cyclophosphamide 20Etoposide 19Temozolomide 16Carboplatin 16Filgrastim 15Vincristine 11Cisplatin 11Radiotherapy 10Thiotepa 9Melphalan 8Granulocyte Colony-Stimulating Factor 8etoposide phosphate 7Lomustine 7Peripheral Blood Stem Cell Transplantation 6Radiation 5Methotrexate 5Magnetic Resonance Spectroscopy 5Topotecan 4Mesna 4Gemcitabine 4Busulfan 4sargramostim 3gallium Ga 68 dotatate 3Thalidomide 3Stem Cell Transplantation 3Irinotecan 3Ifosfamide 3Donepezil 3Celecoxib 3Automobiles 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Medulloblastoma × TPI-287 × Clear all
NCT00867568 2024-08-06

TPI 287 in Patients With Refractory or Recurrent Neuroblastoma or Medulloblastoma

Milton S. Hershey Medical Center

Phase 1 Completed
18 enrolled 12 charts
CNS

Medulloblastoma, Neuroblastoma, Recurrence

NCT01483820 2024-08-06

Safety and Efficacy Study of TPI-287 in Neuroblastoma and Medulloblastoma

Milton S. Hershey Medical Center

Phase 1/2 Terminated
8 enrolled 9 charts
CNS

Medulloblastoma, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡